Weber-Hamann Bettina, Werner Marc, Hentschel Frank, Bindeballe Nils, Lederbogen Florian, Deuschle Michael, Heuser Isabella
Central Institute of Mental Health, J5, 68159 Mannheim, Germany.
Psychoneuroendocrinology. 2006 Apr;31(3):347-54. doi: 10.1016/j.psyneuen.2005.08.014. Epub 2005 Oct 6.
The accumulation of visceral fat is promoted by a specific endocrine syndrome, which is similarly found in major depression. The aim of this study was to investigate whether visceral fat depots increase in depressed patients during a follow-up period explaining the increased risk for cardiovascular disorders. Intraabdominal fat was measured in 29 depressed patients and 17 controls by computer tomography at the level of lumbar vertebra 4. In patients fat measurements were done initially during a major depressive episode and again after a follow-up period of 14 months; in controls the mean time interval between measurements was 28 months. In both groups, saliva was taken at 800 h over a period of seven days prior to each CT for the estimation of free cortisol. In patients only, an oral glucose tolerance test was also carried out. Compared to controls hyper- and normocortisolemic depressed patients showed a larger accumulation of visceral fat mass over time (hypercort.:132.0 +/- 45 vs. 144.7 +/- 47 cm(2), p = 0.07; normocort.: 115.5 +/- 53 vs. 135.0 +/- 51 cm(2), p = 0.002; controls: 130.1 +/- 66 vs. 137.3 +/- 76 cm(2), p = 0.4), despite similar weight gain (hypercort.: 2.1 +/- 5 kg, normocort.: 1.7 +/- 5 kg and controls: 2.3 +/- 4 kg). Further, normocortisolemic patients showed a trend for an higher percentile increase in visceral fat accumulation than controls (23.9 +/- 27 vs. 5.8 +/- 28%, p = 0.07). At follow-up, free cortisol concentrations were still above normal in patients who had been hypercortisolemic at first assessment (35.0 +/- 8 vs. 28.8 +/- 18 nmol/l, p = 0.1). Fasting and 2 h glucose concentrations were higher in hypercortisolemic compared to normocortisolemic patients at the index examination (6.2 +/- 1.1 vs. 5.0 +/- 0.05 mmol/l, p = 0.02; 11.5 +/- 2.7 vs. 7.8 +/- 1.9 mmol/l, p = 0.01). The larger proportion of visceral fat accumulation in patients may constitute a link for explaining the increased cardiovascular mortality in patients suffering from major depression.
一种特定的内分泌综合征会促进内脏脂肪的堆积,而这种综合征在重度抑郁症患者中也同样存在。本研究的目的是调查在随访期间,抑郁症患者的内脏脂肪储存是否会增加,以解释心血管疾病风险增加的原因。通过计算机断层扫描在第4腰椎水平对29名抑郁症患者和17名对照者进行腹部脂肪测量。在患者中,脂肪测量最初在重度抑郁发作期间进行,在14个月的随访期后再次测量;在对照者中,两次测量的平均时间间隔为28个月。在两组中,每次CT检查前7天的8:00采集唾液,用于评估游离皮质醇。仅在患者中还进行了口服葡萄糖耐量试验。与对照者相比,高皮质醇血症和正常皮质醇血症的抑郁症患者随着时间的推移内脏脂肪量积累更多(高皮质醇血症组:132.0±45 vs. 144.7±47 cm²,p = 0.07;正常皮质醇血症组:115.5±53 vs. 135.0±51 cm²,p = 0.002;对照组:130.1±66 vs. 137.3±76 cm²,p = 0.4),尽管体重增加相似(高皮质醇血症组:2.1±5 kg,正常皮质醇血症组:1.7±5 kg,对照组:2.3±4 kg)。此外,正常皮质醇血症患者内脏脂肪积累的百分位数增加趋势高于对照者(23.9±27 vs. 5.8±28%,p = 0.07)。在随访时,首次评估时高皮质醇血症的患者游离皮质醇浓度仍高于正常水平(35.0±8 vs. 28.8±18 nmol/l,p = 0.1)。在首次检查时,高皮质醇血症患者的空腹血糖和2小时血糖浓度高于正常皮质醇血症患者(6.2±1.1 vs. 5.0±0.05 mmol/l,p = 0.02;11.5±2.7 vs. 7.8±1.9 mmol/l,p = 0.01)。患者内脏脂肪积累比例更大可能是解释重度抑郁症患者心血管死亡率增加的一个环节。